Related Experiment Video
Updated: Mar 6, 2026
Single Cell Transcriptional Profiling of Adult Mouse Cardiomyocytes
Published on: December 28, 2011
Microarray Integrated Analysis of a Gene Network for the CD36 Myocardial Phenotype
Imane Sabaouni1, Brigitte Vannier2, Ahmed Moussa3
1Medical Biotechnology Lab (MedBiotech), Rabat Medical & Pharmacy School, Mohammed Vth University in Rabat, Morocco.
Insights
CD36 deficiency causes cardiomyopathy by altering fatty acid metabolism, angiogenesis, and cell structure. This study reveals key gene pathways and networks involved in CD36-related heart disease, offering therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Biochemistry
Background:
- CD36 is a receptor glycoprotein interacting with oxidized LDL and fatty acids.
- The molecular mechanisms underlying CD36 deficiency-induced cardiomyopathy are not fully understood.
Purpose of the Study:
- To identify gene pathways and networks affected by CD36 deficiency in cardiomyopathy.
- To elucidate the molecular mechanisms contributing to CD36-related cardiomyopathy.
Main Methods:
- Utilized bioinformatics tools (STRING, GeneMANIA, Cytoscape) to analyze gene expression differences in CD36-knockout (CD36-KO) mice.
- Identified CD36-regulated genes, their functions, and interaction networks.
Main Results:
- CD36 deficiency impacts genes involved in fatty acid (FA) metabolism.
- Differential gene expression was observed in pathways related to angiogenesis, apoptosis, and cell structure.
- Specific CD36-regulated genes and their functional networks were identified.
Conclusions:
- This study provides novel insights into the molecular mechanisms of CD36 deficiency-induced cardiomyopathy.
- Identified gene pathways offer potential therapeutic targets for treating CD36-related heart conditions.
Abstract:
CD36 is a multifunctional membrane-type receptor glycoprotein that reacts with oxidized low-density lipoprotein and long-chain fatty acid (LCFA). However, much remains to be understood about the molecular mechanism of the cardio-myopathy observed in CD36-KO mice. In this study, we identify different genes pathways involved in response to CD36 cardio-myopathy phenotype by identifying the differences among biological processes, molecular pathways and networks of interactions that emerge from knocking CD3 and using different bioinformatics tools such as STRING, GeneMANIA and Cytoscape. We were able list all the CD36-regulated genes, their related function and their specific networks. Data analysis showed that CD36-regulated genes differentially expressed are involved in biological processes such as FA metabolism, angiogenesis/apoptosis and cell structure. These results provide the first look at mechanisms involved in CD36 deficiency and development of cardio-myopathy and the opportunity to identify new therapeutic targets.
